Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 10 - 27 symbols : SNYNF save search
BioMarin Announces Third Quarter 2021 Financial Results and Corporate Updates
Published: 2021-10-27 (Crawled : 20:00) - prnewswire.com
SNY | News | $47.69 1.15% 1.13% 1.6M
|
Health Technology
|
| O: 0.83%
H: 1.2%
C: 0.32%
BMRN | $92.06 2.87% 2.79% 1.3M
|
Health Technology
|
| O: 2.48%
H: 6.83%
C: 6.39%
financial results results
Sanofi: Information concerning the total number of voting rights and shares - September 2021
Published: 2021-10-27 (Crawled : 19:00) - globenewswire.com
SNY | News | $47.69 1.15% 1.13% 1.6M
|
Health Technology
|
| O: 0.83%
H: 1.2%
C: 0.32%
Patients with Non-Small-Cell Lung Cancer with Brain Metastases: New Data on the Significant Challenges for which Physicians Feel Unequipped
Published: 2021-10-27 (Crawled : 16:00) - prnewswire.com
SNY | News | $47.69 1.15% 1.13% 1.6M
|
Health Technology
|
| O: 0.91%
H: 0.06%
C: -1.04%
lung cancer cancer train brain metastases
Deciduous Therapeutics Announces Appointments to the Board, SAB, and Advisor Roles
Published: 2021-10-27 (Crawled : 15:15) - prnewswire.com
SNY | News | $47.69 1.15% 1.13% 1.6M
|
Health Technology
|
| O: 0.91%
H: 0.06%
C: -1.04%
BioNTech to Report Third Quarter Financial Results and Operational Update on November 9, 2021
Published: 2021-10-27 (Crawled : 14:00) - biospace.com/
SNY | News | $47.69 1.15% 1.13% 1.6M
|
Health Technology
|
| O: 0.91%
H: 0.06%
C: -1.04%
BNTX | News | $88.49 0.55% 0.59% 1K
|
Health Technology
|
| O: -0.4%
H: 1.16%
C: -5.35%
financial results results
Kymera Therapeutics Presents Positive Data Demonstrating Robust IRAK4 Degradation and First Proof-of-Biology with Inhibition of Cytokine Induction from the Single Ascending Dose Portion of KT-474 Phase 1 Trial in Healthy Volunteers
Published: 2021-10-27 (Crawled : 13:15) - biospace.com/
SNY | News | $47.69 1.15% 1.13% 1.6M
|
Health Technology
|
| O: 0.91%
H: 0.06%
C: -1.04%
KYMR | $35.71 3.96% 3.78% 440K
|
Health Technology
|
| O: -0.5%
H: 3.25%
C: 0.66%
phase 1 positive trial
Cytovation announces the appointment of Bo Jesper Hansen as Strategic Advisor
Published: 2021-10-27 (Crawled : 07:00) - prnewswire.com
SNY | News | $47.69 1.15% 1.13% 1.6M
|
Health Technology
|
| O: 0.91%
H: 0.06%
C: -1.04%
Sodexo Fiscal 2021 Results: Solid pick-up in activity and better than expected performance
Published: 2021-10-27 (Crawled : 06:00) - globenewswire.com
SNY | News | $47.69 1.15% 1.13% 1.6M
|
Health Technology
|
| O: 0.91%
H: 0.06%
C: -1.04%
results
Gainers vs Losers
| 76% | 24% |
Top 10 Gainers
AGBA | $2.97 137.6% 54.87% 66M
|
Finance
HKIT | $1.33 30.39% 27.14% 39K
|
Technology Services
VRT 4 | $79.17 4.08% 19.36% 6.6M
|
Electronic Technology
FOA 4 | $0.5144 -8.16% 15.43% 20
|
Finance and Insurance
EAST | $1.0835 16.17% 15.21% 100
|
Commercial Services
BOF | $1.17 6.36% 14.73% 15K
|
LUCY | $0.2545 9.93% 13.94% 66K
|
n/a
MARA | $19.44 10.77% 10.28% 630K
|
Commercial Services
TSLA | News | $144.68 1.85% 9.01% 93M
|
Consumer Durables
BNED | $0.2064 2.64% 8.96% 1.4M
|
Retail Trade
Your saved searches
Save your searches and get alerts when important news are released.